Zovaglutide study in people with kidney problems
Part of Hormones & metabolism clinical trials.
This study tests an investigational drug called Zovaglutide (ZT002) in people with different levels of kidney function, from normal to severely impaired. The goal is to see how the drug is processed by the body and how safe it is for people with kidney problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- Your body mass index (BMI) is between 19 and 32.
- You have had stable chronic kidney disease for at least 3 months (or have normal kidney function for the healthy group).
- Your kidney function level (eGFR) falls into one of the allowed ranges (normal, mild, moderate, or severe impairment).
- You do not have a history of pancreatitis, medullary thyroid cancer, certain mental health conditions, or active cancer in the last 5 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks if a new experimental injection, Zovaglutide, affects the heart's electrical activity (QT interval) in healthy adults. It helps ensure the medicine is safe before it is tested in patients.
This study tests how a new diabetes medicine called ZT002 works in the body and whether it interacts safely with other common medications. Researchers will monitor healthy volunteers who are overweight to understand the medicine's safety and effectiveness.
This study tests whether switching from an existing GLP-1 weight-loss medication (like semaglutide) to a new medicine called zovaglutide is safe and tolerable for adults with obesity. It may help you maintain or improve weight loss with a potentially different medication option.
This study tests a new medicine called zenagamtide for adults with overweight or obesity, with or without type 2 diabetes, who are currently taking semaglutide. The goal is to see how well people tolerate switching from semaglutide to the new treatment.
This trial tests an investigational injection called ZT003 to see if it is safe and how the body processes it. It is for healthy volunteers or those who are overweight or obese, to help understand how this treatment might work.
This trial tests a new medicine Zenagamtide to see if it helps people with excess weight lose more weight than Semaglutide, an existing weight loss drug. You may join if you are an adult with overweight or obesity but do not have diabetes.
Hear when a new Overweight , Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.